1. Home
  2. COHN vs VVOS Comparison

COHN vs VVOS Comparison

Compare COHN & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Company Inc.

COHN

Cohen & Company Inc.

HOLD

Current Price

$16.61

Market Cap

21.6M

Sector

Finance

ML Signal

HOLD

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$2.11

Market Cap

19.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COHN
VVOS
Founded
1999
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.6M
19.4M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
COHN
VVOS
Price
$16.61
$2.11
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.25
AVG Volume (30 Days)
30.8K
114.8K
Earning Date
11-04-2025
11-19-2025
Dividend Yield
5.87%
N/A
EPS Growth
6.29
N/A
EPS
2.50
N/A
Revenue
$185,475,000.00
$17,317,000.00
Revenue This Year
N/A
$17.96
Revenue Next Year
N/A
$55.64
P/E Ratio
$7.41
N/A
Revenue Growth
107.11
18.76
52 Week Low
$6.10
$1.98
52 Week High
$19.22
$7.95

Technical Indicators

Market Signals
Indicator
COHN
VVOS
Relative Strength Index (RSI) 65.92 38.53
Support Level $16.31 $1.98
Resistance Level $19.22 $2.33
Average True Range (ATR) 1.21 0.15
MACD 0.28 0.01
Stochastic Oscillator 61.26 30.77

Price Performance

Historical Comparison
COHN
VVOS

About COHN Cohen & Company Inc.

Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: